Chemino Pharma Limited, a active public limited company, was established on 29 August 2018 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U33100MH2018PLC313189. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹25.00 Cr and a paid-up capital of ₹24.60 Cr.
Formerly known as Chemino Pharma Private Limited, Insunt Trading Private Limited. It upholds a compliant status. Employing 25 professional, Its leadership includes Kiran Parmanand Goklani (Additional Director), Shriraj Sadashiv Shetty (Whole-Time Director), Meghraj Doddanna Shetty (Director). Past directors included Kalpesh Balwantbhai Donga, Shriraj Sadashiv Shetty, Anup Salian. It holds ₹97.19 Cr open charges and ₹35.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 303,3Rd Floor,Western Edge 1,C.T.S. No 163 &165-A Dattapada Road,Borivali East,, Magathane, Mumbai, Maharashtra, 400066.
U33100MH2018PLC313189
313189
29 August 2018
₹25.00 Cr
₹24.60 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Chemino Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kiran Parmanand Goklani | Additional Director | 20 Feb 2025 | Current |
| Shriraj Sadashiv Shetty | Whole-Time Director | 29 Aug 2018 | Current |
| Meghraj Doddanna Shetty | Director | 01 Apr 2023 | Current |
| Sadashiv Kanyana Shetty | Managing Director | 29 Aug 2018 | Current |
| Shreya Sadashiv Shetty | Director | 27 Oct 2021 | Current |
| Chandan Dashrathsingh Rajpurohit | Additional Director | 20 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Oct 2021 | Past |
| Pramod Abcsdd | Director | 16 Mar 2023 | Past |
| Pramod Abcsdd | Cfo | - | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 16 Mar 2023 | Past |
| Pramod Abcsdd | Additional Director | 24 Nov 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Chemino Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 4824.59% increase. The company also saw a substantial improvement in profitability, with a 296.63% increase in profit. The company's net worth moved up by a moderate rise of 5.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Chemino Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹971,893,000.00
₹350,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2025 | Others | ₹1.46 Cr | Open |
| 28 Mar 2024 | Others | ₹9.13 Cr | Open |
| 28 Mar 2024 | Others | ₹8.70 M | Open |
| 25 Oct 2022 | Hdfc Bank Limited | ₹7.29 M | Open |
| 27 Jul 2022 | Others | ₹85.00 Cr | Open |
Explore comprehensive loan charge details -
Chemino Pharma has a workforce of 25 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Chemino Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemino Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 1.46 Cr with Charge ID 101164885 was registered on 18 Sep 2025. was documented.
The activity Chandan Dashrathsingh Rajpurohit was appointed as a Additional Director was appointed as a Additional Director on 20 Mar 2025 & has been associated with this company since 8 months 11 days . was completed.
Progress on Kiran Parmanand Goklani was appointed as a Additional Director was appointed as a Additional Director on 20 Feb 2025 & has been associated with this company since 9 months 9 days . was documented.
Nitin Suresh Belose was appointed as a Cfo was appointed as a Cfo on 09 Jan 2025 & has been associated with this company since 10 months 20 days . was recorded as a recent event.
The activity A charge with Others of Rs. 85.00 Cr registered on 27 Jul 2022 with Charge ID 100603885 was modified on 30 Nov 2024. was completed.
Chemino Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The CIN of Chemino Pharma Limited is U33100MH2018PLC313189.
Chemino Pharma Limited is headquartered at Office No. 303,3Rd Floor,Western Edge 1,C.T.S. No 163 &165-A Dattapada Road,Borivali East,, Magathane, Mumbai, Maharashtra, 400066.
Chemino Pharma Limited was incorporated on 29 August 2018.
The current directors of Chemino Pharma Limited are
The primary industry of Chemino Pharma Limited is Manufacturing.
Chemino Pharma Limited is unlisted.
The authorized capital of Chemino Pharma Limited is ₹25.00 Cr, and the paid-up capital is ₹24.60 Cr.
The compliance status of Chemino Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX